Two Experts. One Protein. And the Mission That Binds Them
A CDI resaerch team has embarked on a drug discovery journey that may lead to new treatment for pediatric nonalcoholic fatty liver disease (NFLD. This serious condition is a troubling consequence of the rise in childhood obesity that can lead to diminished liver function later in life. According to the Centers for Disease Control and Prevention, one in five school-aged children (ages 6-19) is obese.
Molecules to Missiles
CDI funding tests the promise of nanomedicine in brain tumor treatment....Learn More
Works at Work to Find the Origins of Disease
When it comes to childhood diseases, lysosome storage diseases probably aren’t top of mind to most people, but, Abhinav Diwan, MD, medicine, would argue that they should be. ...Learn More
The Future of Augmented Reality is Here
The story of this Children’s Discovery Institute-funded grant started with a phone call. Washington University School of Medicine biomedical engineer Jon Silva, PhD, was at a Microsoft conference and had just seen a demonstration of the Microsoft Hololens, the first self-contained hologram computer. This technology enables its user, who is looking through specially designed goggles, to interact and engage with three-dimensional holograms in their three-dimensional space. They call it augmented reality....Learn More
Immune System: The Body's New Super Hero?
The journal Science Translational Medicine recently published a study showing promise for immunotherapy in treating recurrent acute myeloid leukemia (AML) in adults. The study’s lead author Rizwan Romee, MD, and senior author Todd Fehniger, MD, PhD, from the division of oncology of Washington University School of Medicine, barely let the ink dry before they were on to their next challenge. In collaboration with Jeffrey Bednarski, MD, PhD, pediatrics, they submitted a proposal to and received funding from the Children’s Discovery Institute to pursue the same study in children....Learn More